At MaxCyte®, we are committed to building better cells together. As a leading cell-engineering company, we are driving the discovery, development and commercialization of next-generation cell therapies. Our best-in-class Flow Electroporation® technology and SeQure™ gene editing risk assessment services enable high-performance cell engineering and rigorous evaluation of editing outcomes, supporting confidence in therapeutic development. Supported by expert scientific, technical and regulatory guidance, our platform empowers researchers to engineer diverse cell types and payloads, accelerating the development of safe and effective treatments for human health. For more than 25 years, we’ve been advancing cell engineering, shaping the future of medicine.
Looking for a particular MaxCyte, Inc. employee's phone or email?
MaxCyte, Inc. Questions
The MaxCyte, Inc. annual revenue was $45.4 million in 2026.
Maher Masoud is the CEO of MaxCyte, Inc..
95 people are employed at MaxCyte, Inc..
MaxCyte, Inc. is based in Rockville, Maryland.
The NAICS codes for MaxCyte, Inc. are [54, 54171, 5417, 541, 541714].
The SIC codes for MaxCyte, Inc. are [283, 28].
Top MaxCyte, Inc. Employees
-
Maher Masoud
Chief Executive Officer at MaxCyte, Inc.
Rockville, MD, US24 -
Camille Ciesliga
Chief of Staff and VP, IP at MaxCyte, Inc.
Rockville, MD, US35+ -
Jay Gelfman
Chief Operations Officer at MaxCyte, Inc.
Washington, DC, US24 -
Ron Holtz
EVP Administration at MaxCyte, Inc.
Washington, DC, US25+ -
Sidharth Kapileshwar
Senior Vice President of Corporate Development at MaxCyte, Inc.
Indianapolis, IN, US45+ -
35+ -
Jill Mayer
Vice President, Talent and Teamwork at MaxCyte, Inc.
Montgomery Village, MD, US33 -
Douglas Smith
VP, Science and Innovation at MaxCyte, Inc.
Waltham, MA, US25+
Related Companies
